10% Off 2017

Oakstone Broad Reviews,Clinical Updates,Journal Summaries
Buy Now

PR MDP 1000 GC

Oakstone Practical Reviews Plus $1000 Amazon Gift Card
Buy Now

Order MKSAP18 Today!

The American College of Physicians and Oakstone Program
Buy Now

CME Base Tech Bundle

2017 25% off

10% off Mar 1-Jul 19

$500 Chromebook Tech Bundle


Expert Interviews on Treatment of Multiple Sclerosis: Shifting the Paradigm in 2015

Publisher: The Doctor's Channel
Credits: 0.5
Credit Type: AMA PRA Category 1
Price: Free
Format: Streaming-Video Lectures
Release Date: 4/2/2015
Expiration Date: 4/1/2016
Tags: cme , free cme , the doctor's channel

Expert Interviews on Treatment of Multiple Sclerosis: Shifting the Paradigm in 2015 will equips the attendee with new research in MS pathology and treatment, and also discusses significant differences in the disease and management of patients with progressive forms of MS. Treatment with disease modifying therapies (DMTs) can alter the otherwise debilitating course of multiple sclerosis (MS), a progressive, inflammatory, autoimmune disease of the central nervous system. For persons with established disease, DMTs are aimed toward lowering the amount and harshness of clinical attacks, delaying the onset of disability, and lowering number of lesions within the brain and spinal cord. Over the last several decades, treatment options have been designed for their effect on T cells in the pathogenesis of MS. However, modern data has revealed that B cells and humoral immunity also have an vital role in MS pathogenesis, which is leading to advanced treatment options. With an extensive body of evidence and fresh therapies emerging it is important that clinicians be fluent in up and coming safety, efficacy, and tolerability data as it correleates to existing and investigational agents.
Rating Summary:
0 based on 0 votes

Sign Up For Our Newsletter!

Find us on Facebook!
Find us on Twitter!
Find us on Pinterest!